Biomarkers of Drug Safety: Discovery National Capital Area Chapter Society of Toxicology Fall Symposium November 6, 2007 Lister Hill Auditorium National Library of Medicine Bethesda, MD Program 8:30 AM Registration and Continental Breakfast 9:00 AMWelcome/Opening Remarks Gary Burin, Ph.D. President, NCAC-SOT Donna Mendrick, Ph.D. Vice-President, NCAC-SOT and Program Chair 9:10 AM Computational Framework to Predict Toxicity and Prioritize Testing of Environmental Chemicals Thomas B. Knudsen, Ph.D. Developmental Systems Biologist (title 42) National Center for Computational Toxicology Office of Research & Development 10:00 AM Experience with a Biomarker Consortium William Mattes, Ph.D., D.A.B.T. Director of Toxicology The Critical Path Institute Rockville, MD 10:50 AM Break 11:10 AM A Year of Working through a Biomarker Qualification Pilot Process at the FDA Federico Goodsaid, Ph.D. Genomics Group Office of Clinical Pharmacology Office of Translational Science Center for Drug Evaluation and Research. U.S. Food and Drug Administration Silver Spring, MD 12:00 PM Lunch (Box lunch and beverage included in registration fee) 1:00 PM Bridging Exploratory Biomarkers into Drug Development Joseph Sina, Ph.D. Senior Scientific Director, Systems Toxicology Department of Safety Assessment Mereck & Co., Inc. West Point, PA 1:50 PM Break 2:10 PM Thinking About How a Preclinical Program Can Translate into the Clinic Jerry M. Collins, Ph.D. Associate Director for Developmental Therapeutics Division of Cancer Treatment and Diagnosis, NCI, NIH Bethesda, MD 3:00 PM Monitoring Genetic Toxicity Indicators in Clinical Trials: Pros and Cons David Jacobson-Kram, Ph.D., D.A.B.T. Associate Director for Pharmacology and Toxicology Office of New Drugs Center for Drug Evaluation and Research Silver Spring, MD 20993 3:50 PMClosing Remarks Donna Mendrick, Ph.D. Vice-President, NCAC-SOT and Program Chair 4:00 PM Meeting Adjourned SPEAKER SLIDE PRESENTATIONS (In Adobe Acrobat®)
|
|